Biblio Discovery — Demo Discovery Service

7 results for "Jason Andrade"

Showing 1–7 · 0.55 seconds · RSS

  1. Journal Article Full text

    Thromboembolic risk stratification in atrial fibrillation—beyond clinical risk scores

    Darryl Wan; Jason Andrade; Zachary Laksman

    Reviews in Cardiovascular Medicine, Vol. 22 No. 2 · 2021 · English · DOAJ Scopus

    Atrial fibrillation (AF) is the most common arrhythmia in the adult general population. As populations age, the global burden of AF is expected to rise. AF is associated with stroke and thromboembolic complications, which contribute to significant morbidity and mortality. As a result, it remains…

  2. Journal Article

    The Role of Machine Learning in the Detection of Cardiac Fibrosis in Electrocardiograms: Scoping Review

    Julia Handra; Hannah James; Ashery Mbilinyi et al.

    JMIR Cardio, Vol. 8 · 2024 · English · DOAJ Scopus

    BackgroundCardiovascular disease remains the leading cause of mortality worldwide. Cardiac fibrosis impacts the underlying pathophysiology of many cardiovascular diseases by altering structural integrity and impairing electrical conduction. Identifying cardiac fibrosis is essential for the…

  3. Journal Article

    An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective

    Malte Kuniss; Lucy Hillcoat; Joe Moss et al.

    BMC Health Services Research, Vol. 24 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background Three recent randomized controlled trials demonstrated that, in patients with symptomatic paroxysmal atrial fibrillation (PAF), first-line pulmonary vein isolation with cryoballoon catheter ablation reduces atrial arrhythmia recurrence compared to initial antiarrhythmic drug…

  4. Journal Article

    Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English National Health Service perspective

    Jason Andrade; Stuart Mealing; Derick Todd et al.

    Open Heart, Vol. 11 No. 1 · 2024 · English · DOAJ Scopus

    Introduction Three recent randomised controlled trials have demonstrated that pulmonary vein isolation as an initial rhythm control strategy with cryoablation reduces atrial arrhythmia recurrence in patients with symptomatic paroxysmal atrial fibrillation (PAF) compared with antiarrhythmic drug…

  5. Journal Article

    A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation

    Morten Lock Hansen; Joe W. E. Moss; Jacob Tønnesen et al.

    BMC Cardiovascular Disorders, Vol. 24 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Introduction Three randomised controlled trials (RCTs) have demonstrated that first-line cryoballoon pulmonary vein isolation decreases atrial tachycardia in patients with symptomatic paroxysmal atrial fibrillation (PAF) compared with antiarrhythmic drugs (AADs). The aim of this study was…

  6. Journal Article

    Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

    Jeffrey T. Ha; Anish Scaria; Jason Andrade et al.

    Kidney Medicine, Vol. 5 No. 7 · 2023 · English · DOAJ Scopus

    Rationale & Objective: The benefit–risk profile of rivaroxaban versus warfarin for atrial fibrillation (AF) in patients with chronic kidney disease is uncertain. We compared rivaroxaban with warfarin across the range of kidney function in adults with AF. Study Design: Multicenter retrospective…